Literature DB >> 1663584

G-protein coupling and signalling of Y1-like neuropeptide Y receptors in SK-N-MC cells.

F Feth1, W Rascher, M C Michel.   

Abstract

We have studied [125I]neuropeptide Y-binding sites and neuropeptide Y-mediated second messenger responses in human SK-N-MC neuroblastoma cells with special reference to the role of G-proteins. Neuropeptide Y stimulated two second messenger responses in SK-N-MC cells, inhibition of cAMP accumulation and mobilization of Ca2+ from intracellular stores. Both effects were completely abolished by pretreatment with pertussis toxin. Binding of [125I]neuropeptide Y to intact cells or SK-N-MC cell membranes was rapid, reversible, characterized by high affinity and low capacity, and had pharmacological characteristics of a homogeneous population of Y1-like neuropeptide Y receptors. In permeabilized cells, [125I] neuropeptide Y binding was inhibited by GTP gamma S in a concentration-dependent manner. Saturation experiments in the absence and presence of GTP gamma S demonstrated a reduction in the number of high-affinity [125I]neuropeptide Y-binding sites without a decrease in affinity of the remaining sites. Pretreatment of intact cells with pertussis toxin completely abolished the inhibition of [125I]neuropeptide Y binding by GTP gamma S. Moreover, pertussis toxin treatment reduced the number of high-affinity [125I]neuropeptide Y binding sites. We conclude that the agonist ligand [125I]neuropeptide Y identifies functional neuropeptide Y receptors in SK-N-MC cells; however, the number of specific [125I]neuropeptide Y-binding sites may not necessarily reflect the number of neuropeptide Y receptors, because the former is affected by the functional state of cellular G-proteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663584     DOI: 10.1007/bf00167376

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.

Authors:  P Valet; M Berlan; M Beauville; F Crampes; J L Montastruc; M Lafontan
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

Review 2.  Neuropeptide Y as an autonomic neurotransmitter.

Authors:  E K Potter
Journal:  Pharmacol Ther       Date:  1988       Impact factor: 12.310

3.  Neuropeptide Y inhibits cardiac adenylate cyclase through a pertussis toxin-sensitive G protein.

Authors:  S Kassis; M Olasmaa; L Terenius; P H Fishman
Journal:  J Biol Chem       Date:  1987-03-15       Impact factor: 5.157

4.  Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.

Authors:  C Wahlestedt; N Yanaihara; R Håkanson
Journal:  Regul Pept       Date:  1986-02

5.  [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.

Authors:  J Fuhlendorff; U Gether; L Aakerlund; N Langeland-Johansen; H Thøgersen; S G Melberg; U B Olsen; O Thastrup; T W Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Pertussis toxin treatment of whole blood. A novel approach to assess G protein function in congestive heart failure.

Authors:  A S Maisel; M C Michel; P A Insel; C Ennis; M G Ziegler; C Phillips
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

7.  Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.

Authors:  E A Gordon; T A Kohout; P H Fishman
Journal:  J Neurochem       Date:  1990-08       Impact factor: 5.372

8.  Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro.

Authors:  M C Michel; E Schlicker; K Fink; J H Boublik; M Göthert; R N Willette; R N Daly; J P Hieble; J E Rivier; H J Motulsky
Journal:  Am J Physiol       Date:  1990-07

9.  Two different G-proteins mediate neuropeptide Y and bradykinin-stimulated phospholipid breakdown in cultured rat sensory neurons.

Authors:  T M Perney; R J Miller
Journal:  J Biol Chem       Date:  1989-05-05       Impact factor: 5.157

10.  Inhibition of noradrenaline release by neuropeptide Y in mouse atria does not involve inhibition of adenylate cyclase or a pertussis toxin-susceptible G protein.

Authors:  S Foucart; H Majewski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

View more
  7 in total

1.  Differential calcium signalling by m2 and m3 muscarinic acetylcholine receptors in a single cell type.

Authors:  M Schmidt; C Bienek; C J van Koppen; M C Michel; K H Jakobs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

2.  Alpha 1A and alpha 1B-adrenoceptors enhance inositol phosphate generation in rat renal cortex.

Authors:  M C Michel; R Büscher; T Philipp; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

3.  Rapid desensitization of adrenaline- and neuropeptide Y-stimulated Ca2+ mobilization in HEL-cells.

Authors:  M C Michel
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

4.  A study of NPY-mediated contractions of the porcine isolated ear artery.

Authors:  R E Roberts; D A Kendall; V G Wilson
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  NPY and carbachol raise Ca2+ in SK-N-MC cells by three different mechanisms. Evidence for inositol phosphate-independent Ca2+ mobilization by NPY.

Authors:  M C Michel; F Feth; M Stieneker; W Rascher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

6.  Neuropeptide Y (NPY) receptors in HEL cells: comparison of binding and functional parameters for full and partial agonists and a non-peptide antagonist.

Authors:  F Feth; W Rascher; M C Michel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

7.  Neuropeptide Y2-type receptor-mediated activation of large-conductance Ca(2+)-sensitive K+ channels in a human neuroblastoma cell line.

Authors:  V S Lemos; K Takeda
Journal:  Pflugers Arch       Date:  1995-08       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.